Want to see HK:1177 full AI Analyst Report?
Sino Biopharmaceutical (1177) Stock Forecast & Price Target
1177 Analyst Ratings
Strong Buy
10Buy0Hold0Sell
Based on 10 analysts giving stock ratings to Sino Biopharmaceutical in the past 3 months
1177 Stock 12 Month Forecast
Average Price Target
HKD 8.93▲(85.27% Upside)Based on 10 Wall Street analysts offering 12 month price targets for Sino Biopharmaceutical in the last 3 months. The average price target is HKD 8.93 with a high forecast of HKD 10.80 and a low forecast of HKD 7.00. The average price target represents a 85.27% change from the last price of HKD 4.82.
Past 12 Months12 Month ForecastDec2025Sep2026
HighHKD 10.80
AverageHKD 8.93
LowHKD 7.00
Highest Price TargetHighestHKD 10.80Average Price TargetHKD 8.93Lowest Price TargetLowestHKD 7.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | UBS | HKD 7.70 | buy | 59.75%Upside | Reiterated | 10/28/26 | ||
| Unknown AnalystNot Ranked | Guosheng Securities | HKD 8.20 | buy | 70.12%Upside | Reiterated | 09/04/26 | ||
| Unknown AnalystNot Ranked | Shenwan Hongyuan | HKD 10.40 | buy | 115.77%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | China Merchants Securities | HKD 9.80 | buy | 103.32%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | HKD 7.70→HKD 10 | buy | 107.47%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | CMB International Securities | HKD 8.70 | buy | 80.50%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Citi | HKD 10→HKD 10.80 | buy | 124.07%Upside | Reiterated | 08/20/26 | ||
| Unknown AnalystNot Ranked | CICC | HKD 8.90 | buy | 84.65%Upside | Reiterated | 08/20/26 | ||
| Alexis Yan | Morgan Stanley | HKD 7.80 | buy | 61.83%Upside | Reiterated | 08/19/26 | ||
| Unknown AnalystNot Ranked | Daiwa | HKD 7 | buy | 45.23%Upside | Reiterated | 08/12/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | HKD 7.20 | buy | 49.38%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | Nomura | HKD 8.26 | buy | 71.37%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | HSBC | HKD 8.50 | buy | 76.35%Upside | Reiterated | 07/10/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | HKD 9 | buy | 86.72%Upside | Reiterated | 06/25/26 | ||
| Mark Kong CFA | DBS | HKD 6.50 | buy | 34.85%Upside | Initiated | 05/20/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/28/26 | HKD 7.70 | buy | 59.75%Upside | Reiterated | UBS | ||
| Unknown AnalystNot Ranked | 09/04/26 | HKD 8.20 | buy | 70.12%Upside | Reiterated | Guosheng Securities | ||
| Unknown AnalystNot Ranked | 08/26/26 | HKD 10.40 | buy | 115.77%Upside | Reiterated | Shenwan Hongyuan | ||
| Unknown AnalystNot Ranked | 08/25/26 | HKD 9.80 | buy | 103.32%Upside | Reiterated | China Merchants Securities | ||
| Unknown AnalystNot Ranked | 08/21/26 | HKD 7.70→HKD 10 | buy | 107.47%Upside | Reiterated | BOCOM International Holdings Company | ||
| Unknown AnalystNot Ranked | 08/21/26 | HKD 8.70 | buy | 80.50%Upside | Reiterated | CMB International Securities | ||
| Unknown AnalystNot Ranked | 08/20/26 | HKD 10→HKD 10.80 | buy | 124.07%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 08/20/26 | HKD 8.90 | buy | 84.65%Upside | Reiterated | CICC | ||
| Alexis Yan | 08/19/26 | HKD 7.80 | buy | 61.83%Upside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 08/12/26 | HKD 7 | buy | 45.23%Upside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 07/24/26 | HKD 7.20 | buy | 49.38%Upside | Reiterated | UOB Kay Hian | ||
| Unknown AnalystNot Ranked | 07/24/26 | HKD 8.26 | buy | 71.37%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 07/10/26 | HKD 8.50 | buy | 76.35%Upside | Reiterated | HSBC | ||
| Unknown AnalystNot Ranked | 06/25/26 | HKD 9 | buy | 86.72%Upside | Reiterated | Citic Securities | ||
| Mark Kong CFA | 05/20/26 | HKD 6.50 | buy | 34.85%Upside | Initiated | DBS |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Sino Biopharmaceutical
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
0.00%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-4.40%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -4.40% per trade.
2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-4.40%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -4.40% per trade.
1177 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 9 | 14 | 12 | 7 |
| Buy | 1 | 3 | 4 | 5 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 12 | 18 | 17 | 10 |
In the current month, 1177 has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1177 average Analyst price target in the past 3 months is 8.93.
1177 Financial Forecast
HighHKD 0.12
ConsensusHKD 0.11
LowHKD 0.09
1177 Earnings Forecast
Next quarter’s earnings estimate for 1177 is HKD 0.11 with a range of HKD 0.09 to HKD 0.12. The previous quarter’s EPS was HKD 0.22. 1177 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1177 has Performed in-line its overall industry.
HighHKD 19.8B
ConsensusHKD 19.6B
LowHKD 19.5B
1177 Sales Forecast
Next quarter’s sales forecast for 1177 is HKD 19.64B with a range of HKD 19.46B to HKD 19.84B. The previous quarter’s sales results were HKD 22.17B. 1177 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1177 has Performed in-line its overall industry.
1177 Stock Forecast FAQ
What is HK:1177’s average 12-month price target, according to analysts?
Based on analyst ratings, Sino Biopharmaceutical’s 12-month average price target is HK$8.93.
What is HK:1177’s upside potential, based on the analysts’ average price target?
Sino Biopharmaceutical has 85.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sino Biopharmaceutical a Buy, Sell or Hold?
Sino Biopharmaceutical has a consensus rating of Strong Buy, which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sino Biopharmaceutical’s share price target?
The average share price target for Sino Biopharmaceutical is HK$8.93. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$10.80, and the lowest forecast is HK$7.00. The average share price target represents a 85.27% increase from the current price of HK$4.82.
What do analysts say about Sino Biopharmaceutical?
Sino Biopharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Sino Biopharmaceutical?
To buy shares of HK:1177, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.